生物工程下游技术-第一章.ppt

1、第一章 生物反应器Bioreactor,Section One,A bioreactor is a vessel in which is carried out a chemical process which involves organisms or biochemically active substances derived from such organisms. Bioreactors are commonly cylindrical, ranging in size from some liter to cube meters, and are often made of sta

2、inless steel.,Bioreactor,Bioreactor design is quite a complex engineering task. Under optimum conditions the microorganisms or cells will reproduce at an astounding rate. The vessels environmental conditions like gas (i.e., air, oxygen, nitrogen, carbon dioxide) flow rates, temperature, pH and disso

3、lved oxygen levels, and agitation speed need to be closely monitored and controlled.,One bioreactor manufacturer, Broadley-James Corporation, uses vessels, sensors, controllers, and a control system, digitally networked together for their bioreactor system.,1. Introduction,Crude medicinal preparatio

4、ns that were aqueous or alcoholic extracts of plant materials were known for centuries to practitioners of the indigenous methods of medicine.,The pain-killing salicylates and antimalarial compounds extracted from the bark of certain trees are notable examples of older medicines. Similarly, animal o

5、rgans such as the pancreas, placenta, and the urine of pregnant females have been a source of hormones for therapeutic use.,Until recently, human albumin was manufactured from pools of human placenta collected from Third World countries. But the high risk of virus contamination from unidentified don

6、ors of placenta and the impracticality of identifying the donors, forced the discontinuation of this process. Today, plasma from unpaid donors is the major source of albumin and the risk of transmission of viruses calls for extensive purification including the use of dedicated virus removal and inac

7、tivation steps to render the product safe for human use.,Although crude preparations from plant or animal sources are still used as medicinals in some parts of the world, modern medicines in most countries are extremely pure. The high level of drug safety and purity are demanded by the regulatory au

8、thorities in such countries as the United States, Europe, and Japan. Fortunately, the biopharmaceutical industries are able to meet the stringent demands because they have access to a variety of excellent purification techniques.,The science of biotechnology covers the exploitation of microorganisms

9、 and cell cultures, which form the major source of high value compounds. More recently, geneticists have succeeded in breeding transgenic sheep and goats, and methods have been developed to get these animals to express the desired products in their milk. The industry today manufactures on a large sc

10、ale compounds that would otherwise have been difficult, if not impossible, to produce in significant quantities for treating many diseases.,Whether produced from plants, animal tissue, microorganisms, or from cell culture, the desired products are present in rather complex process streams and need e

11、xtensive purification. A great majority of these products are proteins, which makes this task even more difficult. If these were nonprotein molecules, such as antibiotics for example, one could use simpler solvent extraction methods to isolate the compounds from the solutions in which they are prese

12、nt.,Thus, in the biotechnology industry, there is quite a challenge to the biochemists and chemical engineers in the downstream processing departments of the companies. They employ diverse purification methods in the research laboratory at the bench scale and these are eventually scaled up to the pr

13、oduction floor. The methods are used in complementary fashion to develop cost-effective methods in quick time and enable the companies to bring the products to market ahead of their competitors.,This chapter attempts to give the reader an overview of the techniques available for downstream purificat

14、ion of biotechnology products. Readers are advised to refer to specific chapters in later sections of this volume where these techniques are described in detail.,As stated before, the industry manufactures products from a number of sources and their downstream processing varies not only from product

15、 to product, but also varies depending on the source of the product. Each process, therefore, needs to be finely tailored depending on the properties of the product and the process stream from which it is recovered and purified.,2. Manufacturing Processes in the Industry,2.1. Products of Recombinant

16、 Bacterial Fermentation,The first step in these processes is the separation of the biomass from its surrounding broth. The protein of interest is expressed within the cell as a soluble protein, but it is quite often present in the form of an insoluble refractive mass called the “inclusion bodies.”,T

17、he recovery of the biomass is sometimes performed by preparative centrifugation, but the preferred method today is by means of tangential-flow filtration systems using microporous membranes of appropriate pore diameters.,The different filter manufacturers like Millipore Corporation (Bedford, MA), Pa

18、ll Corp. (Port Washington, NY) and other companies offer membranes with 0.22, 0.45, and 0.65 m pore sizes, and the scientists developing the process select the membranes best suited to their needs of biomass concentration.,The particulates from the process fluids can get into the membrane pores and

19、cause a significant drop in filtration rates. The phenomenon can be controlled by fine tuning the process conditions to obtain the optimum feed and permeate flow rates and transmembrane pressures.,The composition of the fermentation broths can have significant effects on the filtration rates. One co

20、mponent that has such an impact is the antifoam used to control foaming during fermentation. These hydrophobic chemicals are quickly absorbed to the surface of the membrane and cause a drop in flux.,Under certain process conditions such as temperature for example, some antifoams come out of solution

21、 to form insoluble micelles, which can easily adsorb to the membrane surface. Therefore, an appropriate antifoam is selected for the fermentation process bearing in mind the downstream processing steps.,During cell harvesting, simultaneous cell washing (also referred to as diafiltration) can be perf

22、ormed by adding a suitable solution to the cell concentrate, which also helps to maintain the desired pH or ionic strength of the cell suspension to avoid cell lysis.,Diafiltration also helps to wash away the soluble impurities from the process stream. This step is usually started when the cell conc

23、entration reaches a specific point where rapid flux decay is observed.,2.2. Cell Lysis and Clarification of the Lysate,The recovered bacterial cell mass is next lysed by mechanical cell disruption under high pressure. This step releases the desired product from inside the cells for further processin

24、g.,The lysate, which consists of both soluble and insoluble components, notably the cell debris, is then clarified by a tangential flow filtration step with an appropriate membrane device.,Here, once again, the choice of the right microporous membrane is critical. The smaller pore diameters, such as

25、 the 0.22 m, perform better. The larger pores can get plugged by the cell debris or other particulate contaminants.,However, ultrafiltration membranes with even smaller pore diameters most often perform better than the microporous membranes because the debris cannot get lodged in the pores.,One can,

26、 therefore, avoid flow decay. However, the fluxes through the ultrafiltration membranes are, in general, lower than those with the microporous membranes. If the desired protein is in the soluble fraction of the lysate, it passes the membrane in this step to end up in the permeate and it is then sent

27、 to the next purification step.,If the product is present as inclusion bodies, it is present in the retentate of the above step and has to be first solubilized by the addition of an agent such as guanidine or urea. The solubilized protein is then separated from the particulates by ultrafiltration. T

28、he selected membrane should permit the passage of the solubilized protein while retaining the debris and particulates in the retentate.,2.3. Harvesting Mammalian Cell Cultures,The desired products in these fermentation processes are in the extracellular fraction. If the cells are lysed during the ce

29、ll concentration, the intracellular proteins can spill out of the cells and contaminate the extracellular product.,The extremely fragile mammalian cells, therefore, need careful handling. An elevated transmembrane pressure and high filtration rates can damage the cells. An excellent membrane-based t

30、angential-flow filtration system was developed by Millipore in the early 1980s.,The system contains a microporous membrane, usually with pore diameters of 0.45 m, a feed pump much like in the conventional TFF systems, but a permeate pump replaces the usual valve used for restricting the permeate flo

31、w. The second pump helps to accurately control the permeate flux and to maintain a low transmembrane pressure. Under high transmembrane pressures, the fragile cells can be pushed into the membrane pores and get damaged. With these systems, a high product recovery can be achieved without cell lysis.

32、Diafiltration helps to further improve product recovery.,Aggregates of proteins and colloidal material are also retained, and care must be taken to make sure that the desired protein is recovered in good yields in the permeate. Washing the retentate with a suitable buffer helps to improve the protei

33、n recovery in the permeate. The product is then sent for further purification.,Section Two,第一节 概述 各种细胞及其代谢产物的生产过程都要通过细胞的培养，而细胞培养所用的装置就是反应器。 生物反应器的作用：就是要为细胞代谢提供一个优化的物理及化学环境，使细胞能更快更好地生长，得到更多的需要的生物量或代谢产物。 生物反应器：生物反应器是利用酶或生物体（如微生物）所具有的生物功能，在体外进行生化反应的装置系统，是一种生物功能模拟机，如发酵罐、固定化酶或固定化细胞反应器等。,如何使细胞生长的更快更好？,一、好

34、的细胞株系 二、良好的环境条件 1、良好的物理环境：最主要的有温度、pH、溶氧量、合适的混合强度以保证细胞与营养物的接触及细胞的悬浮等。 2、合适的化学环境：要求有合适的各种营养物的浓度，并限制各种妨碍生长代谢的有毒物质的浓度。,研究生物反应器的目的,1、确定为达到一定的生产目的需要多大的生物反应器，什么样的结构更好。 2、对已有的生物反应器进行分析，达到优化的目的。 3、分析各种生物反应器的数据，从而对细胞的生长、代谢等过程有更加深入的理解。 （生物反应器是工程学的一部分也是化学工程的一个分支）,化学工程还包括下面几个重要的内容,1、流体的输送及混合。核心问题是流体之间动量的传递、机械能的转

35、化。 2、热量的传递。生物反应器要考虑发酵热的传出以及发酵罐温度的控制。 3、物质的传递。生物反应器内进行着各种物质传递过程，这些传递过程的强度主要由浓度差以及扩散的面积决定。,第二节 细胞生长及代谢过程动力学,一、细胞生长的特点、描述方法的分类 二、细胞的浓度及其测量 三、均衡生长模型 四、其它模型,一、细胞生长的特点、描述方法的分类,（一）细胞培养 1、细胞培养的一般条件 温度 pH 渗透压 营养物 水 无菌条件 光 气体,2、动物细胞培养的特殊条件,(1)血清：动物细胞离体培养常常需要血清。最常用的是小牛血清。血清提供生长必需因子，如激素、微量元素、矿物质和脂肪。 (2)支持物：大多数动

36、物细胞有贴壁生长的习惯。离体培养常用玻璃，塑料等作为支持物。 (3)气体交换：二氧化碳和氧气的比例要在细胞培养过程中不断进行调节，不断维持所需要的气体条件。,3、植物细胞培养的特殊条件,(1)光照：离体培养的植物细胞对光照条件不严格，因为细胞生长所需要的物质主要是靠培养基供给，但光照不但与光合作用有关，而且与细胞分化有关。 (2)激素：植物细胞的分裂和生长特别需要植物激素的调节，促进生长的生长素和促进细胞分裂的分裂素是最基本的激素。,4、微生物细胞培养的特殊条件,微生物多为单细胞生物，野生生存条件比较简单。 所以微生物人工培养的条件比动植物细胞简单得多。其中厌氧微生物培养比好氧微生物复杂。 微

37、生物对培养条件要求不如动植物细胞那样苛刻，玉米浆、蛋白胨、麦芽汁、酵母膏等成为良好的微生物天然培养基。,（二）描述方法,常用的有：,反应速率：单位时间物质浓度的变化量。如：细胞的生长速率、代谢产物的生成速率等。 得率系数：两种物质得失之间的计量比。如：菌体的生成量对基质消耗量的得率系数。 比速率：单位浓度的菌体、单位时间引起某物质浓度的变化量。如：菌体的比生长速率、基质的比消耗速率、产物的比生成速率。,理想流动和非理想流动,两种理想流动模式 全混式，即反应器内各点浓度及其它条件均一。 活塞流式，即反应器内物质沿一定方向流动，完全没有反向混合。 实际反应装置常常介于两者之间。,细胞生长的特点及细

38、胞群体的描述,细胞的生长、代谢是一个复杂的生物化学过程 与一般的化学过程不同，这个反应体系的特点是，它是一种多相、多组分、非线性的体系。 细胞的培养和代谢还是一个复杂的群体的生命活动，通常每毫升培养液中含104-108个细胞。而且，像任何有生命的东西一样，细胞也经历着新生、成长、成熟直至衰老的过程，在其生命的循环中，也存在退化与变异的问题。,细胞群体进行简化假设,是否考虑细胞内部复杂的结构 是否考虑细胞之间的差别,4种模型,非离散的结构模型,文献上简称结构模型。这种模型把细胞分为具有不同生理功能的组分。 这种模型考虑到胞内不同的结构单元，对更精细地分析细胞的代谢调控是很重要的，其分析结果对于过程的优化往往具有指导作用。 结构模型考虑了胞内各结构单元的代谢及相互作用，因此列出的方程参数多、复杂，不容易解，即使用计算机求解也要花费相当的时间，因此在过程控制中较少用这种模型。,离散型非结构模型,把细胞分为几种不同形态或功能的类别。总的细胞量是各类细胞量的和，各类细胞有不同的生理功能。 对于培养中细胞有明显差别（形态、功能）的过程用此种离散模型最好。 缺点：分别测出各类细胞量是有困难的。,离散型结构模型,细胞培养的实际情况。细胞之间不均一，细胞内部